|
|
News Breaks
|
November 24, 2009
|
| 07:07 EDT |  | MITI |
| theflyonthewall.com: | Micromet in agreement with Lonza for Blinatumomab manufacturing | | Micromet a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases today announced that it has entered into an agreement for the process development and manufacture of blinatumomab with Lonza AG, a market leading custom manufacturer of antibodies and other biologics. Under the terms of the agreement, Lonza will manufacture blinatumomab for clinical trials. In addition, Lonza will develop the commercial scale process and will supply blinatumomab for the market if so requested by Micromet. :theflyonthewall.com |
|
|
News For MITI From The Last 14 Days Check below for free stories on MITI the last two weeks.
| Sign up for a free trial to see the rest of the stories you've been missing. |
There are no results for these search parameters.
|
|
|
|
